Wuxi Biologics Placement: A Larger Deal but Performance Track Record Weighs
Wuxi Biologics is looking to raise upto US$770m by selling 35 million primary shares and selling 35million shares held by its main shareholder Wuxi...
508 Views
Shanghai/Shenzhen Connect Ideas: Wuliangye Vs Moutai (2019-08-23)
In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...
443 Views
Pharmaron Beijing IPO Initiation: Clinically Sound
Pharmaron Beijing Co., Ltd. (A) (300759 CH) is a global contract research organisation (CRO) and is one of the top three drug discovery service...
531 Views
Pharmaron (康龙化成) A+H Listing: A Leading Drug Discovery Company
Pharmaron, a leading contract research company, is looking to list on the H-Share market by raising up to USD 600 million. In this insight, we will...
622 Views
Shanghai/Shenzhen Connect Ideas: Home Appliances & Hard Liquors (2019-08-23)
In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...
477 Views